Back
Lexeo Therapeutics, Inc. Common Stock LXEO · Insights
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, ded... Price3.14
Market Cap257.64 M
Float81.86 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro